Skip to main content
. 2020 Jan 27;130(3):1363–1376. doi: 10.1172/JCI131838

Figure 2. Schematic of the Utah CAD study design and the subset of available biospecimens used for LC-MS/MS sphingolipid analysis.

Figure 2

Machine learning was applied to the sphingolipidomic data to develop novel scores that associated with CAD beyond conventional lipid markers, such as cholesterol (created with BioRender).